Vimarsana
Biggest News Aggregation in the World

Page 10 - Senza Omnia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Senza Omnia Today - Breaking & Trending Today

Nevro Corp. (NYSE:NVRO) Receives $39.73 Consensus Price Target from Analysts - Vimarsana News

Nevro Corp. (NYSE:NVRO) Receives $39.73 Consensus Price Target from Analysts

Shares of Nevro Corp. (NYSE:NVRO – Get Rating) have received an average recommendation of “Hold” from the twelve ratings firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating on the […]

Source: wkrb13.com
Zacks Research Comments on Nevro Corp.'s Q1 2024 Earnings (NYSE:NVRO) - Vimarsana News

Zacks Research Comments on Nevro Corp.'s Q1 2024 Earnings (NYSE:NVRO)

Nevro Corp. (NYSE:NVRO – Get Rating) – Investment analysts at Zacks Research lifted their Q1 2024 earnings estimates for shares of Nevro in a research report issued on Monday, June 19th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings per share of ($0.96) for the quarter, up from […]

Nevro Corp. (NYSE:NVRO) Receives $39.73 Average PT from Brokerages - Vimarsana News

Nevro Corp. (NYSE:NVRO) Receives $39.73 Average PT from Brokerages

Nevro Corp. (NYSE:NVRO – Get Rating) has been assigned an average recommendation of “Hold” from the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating on the company. […]

Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions - Vimarsana News

Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Hold" from Brokerages - Vimarsana News

Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Hold" from Brokerages

Nevro Corp. (NYSE:NVRO – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average […]